"Statements suggesting AI is inherently better informed than physicians, or that physicians cannot be trusted to make clinical decisions without first consulting this technology, diminish physician expertise and risk undermining patients’ trust."
This stark warning from six of the nation’s largest physician organizations underscores a growing tension at the intersection of artificial intelligence and healthcare. The organizations contend that claims of AI’s superior medical knowledge, particularly those voiced by high-profile officials, threaten to erode the foundational trust between patients and their doctors, potentially jeopardizing patient safety. This debate, ignited by remarks from Health and Human Services Secretary Robert F. Kennedy Jr., extends far beyond policy circles, impacting how everyday individuals interact with health information and technology.
The controversy erupted on September 30th when a joint statement was released by the American Medical Association, the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American College of Physicians, and the American College of Surgeons. These influential groups, representing a vast majority of family physicians, pediatricians, obstetricians, gynecologists, internists, and surgeons, voiced their profound concern over recent rhetoric suggesting AI possesses an inherent informational advantage over human physicians. This statement directly challenged remarks made by HHS Secretary Robert F. Kennedy Jr. the previous day, September 29th, at the Make America Healthy Again Summit in Washington, D.C.
During a fireside chat with Vice President JD Vance, Secretary Kennedy articulated a strong case for AI as a tool that could empower patients. According to reporting by Fierce Healthcare, he stated that AI can provide patients with a second opinion that is "much better informed than any doctor in the country" and has the potential to "free us from medical tyranny." Kennedy framed AI as a crucial mechanism for patients to independently verify official health advice, offering examples such as questioning the efficacy of masks, social distancing protocols, and vaccines by referencing potential AI-generated counterarguments. He even recounted a conversation with OpenAI CEO Sam Altman, who reportedly suggested that failing to consult AI for diagnoses or prescriptions would soon constitute medical malpractice.
Kennedy’s rationale was primarily centered on enhancing patient access to information. He envisioned a future where "every American will have access on their cell phones to their own medical records," with AI capable of summarizing this data for easier patient comprehension. The summit itself, as noted by Fierce Healthcare, had corporate sponsors including significant players in the technology sector like Walmart, OpenAI, and Anthropic, highlighting the growing influence of these companies in the health landscape. As of October 6th, the Department of Health and Human Services had not publicly responded to the physician groups’ statement.
The physician organizations, while not outright rejecting AI in medicine, emphasized its role as a supportive tool for clinicians rather than a replacement. Their joint statement articulated a clear boundary: "Statements suggesting AI is inherently better informed than physicians, or that physicians cannot be trusted to make clinical decisions without first consulting this technology, diminish physician expertise and risk undermining patients’ trust." They underscored the irreplaceable nature of human clinical judgment, noting that physicians "ask questions, understand each patient’s unique needs and circumstances, exercise professional judgment and take responsibility for the care they provide." While acknowledging the "tremendous potential" of AI, the groups stressed that "patient safety, physician expertise and the humanity of clinical practice must guide how these tools are developed and used." The overarching sentiment was a call for caution: "We need to move carefully, and we need to get this right." Notably, the statement did not directly address Secretary Kennedy’s specific examples concerning masks, social distancing, or vaccines.
The divergence in perspective is particularly noteworthy given the increasing adoption of AI by physicians themselves. An AMA survey from 2026 indicated a significant surge in AI utilization among doctors, with 81% reporting its use, a substantial jump from 38% in 2023, as reported by Healthcare Finance News. This indicates that the debate is not about whether AI belongs in healthcare, but rather about the locus of decision-making authority and the potential ramifications for patient trust and safety.
The public is already actively engaging with AI for health-related queries, often outpacing policy discussions. A KFF poll conducted between February 24th and March 2nd, 2026, revealed that one-third of U.S. adults (32%) had utilized AI chatbots for health information or advice in the preceding year. The trend was even more pronounced among younger demographics, with 36% of adults under 30 seeking AI assistance for physical health questions and 28% for mental health concerns.
Factors such as cost and accessibility significantly influence this adoption. KFF data indicates that one in five adults who turn to AI for health reasons cite difficulties in accessing or affording traditional medical care, making chatbots an attractive, immediate, and often free alternative. However, the potential risks associated with AI in healthcare are substantial and well-documented. The patient safety nonprofit ECRI identified the misuse of AI chatbots as the leading health technology hazard for 2026. Their findings highlighted instances where chatbots provided incorrect diagnoses, recommended unnecessary tests, and even fabricated anatomical information, as detailed by Fierce Healthcare. ECRI’s president and CEO, Dr. Marcus Schabacker, emphasized the inherent limitations of these tools: "While chatbots are powerful tools, the algorithms cannot replace the expertise, education, and experience of medical professionals." He further cautioned that chatbots are "programmed to sound confident and to always provide an answer to satisfy the user, even when the answer isn’t reliable."
Public opinion on the capabilities of AI in healthcare remains divided. An Edelman survey spanning 13 countries found that nearly half (49%) of respondents believed that individuals without formal medical training, but proficient in using AI, could perform certain health tasks as effectively as or even better than trained healthcare professionals, a finding previously reported by MedicalDaily. It is crucial to note that no study cited in coverage of the summit has demonstrated that general-purpose AI chatbots are more informed than physicians in the context of real-world patient care. While AI can excel at specific, narrowly defined tasks, its ability to answer a multiple-choice question in a medical exam is fundamentally different from the complex process of examining a patient, understanding their unique context, and taking professional responsibility for the diagnostic and therapeutic outcomes.
The responsible integration of AI into healthcare necessitates a clear understanding of its capabilities and limitations. AI chatbots can serve as valuable adjuncts for patients, aiding in the formulation of questions for their physicians, clarifying complex medical terminology, and providing supplementary explanations for diagnoses already provided by a clinician. However, their use as the definitive source for initiating or discontinuing medication, determining the urgency of symptoms, or interpreting intricate test results carries significant risks.
ECRI strongly advises patients to verify any information obtained from chatbots with credible sources, which invariably means consulting with a qualified healthcare professional. This verification process should precede any action taken based on AI-generated advice. Specifically, patients should never stop or alter prescribed medications based on a chatbot’s recommendation without first consulting their doctor or pharmacist.
The stakes are particularly high for individuals with chronic conditions, pregnant patients, parents of young children, and those caring for elderly relatives. In these populations, errors in medication dosing or triage decisions can rapidly escalate into serious health crises. Symptoms such as chest pain, difficulty breathing, signs of stroke, sudden onset of confusion, or a rapidly deteriorating condition warrant immediate emergency medical attention and should not be managed or delayed by consulting an AI chatbot.
As the Department of Health and Human Services continues to advance initiatives aimed at expanding patient access to digital health records and AI-driven tools, this debate is likely to intensify. For the foreseeable future, the most prudent approach for most families is to leverage AI as a catalyst for more informed discussions with their healthcare providers. AI can help patients prepare better questions and gain a preliminary understanding of their health, but the ultimate responsibility for diagnosis and treatment must remain with licensed clinicians who possess the comprehensive knowledge, experience, and ethical framework to manage the full spectrum of patient care.
